Nanoviricides NNVC
NYSE NNVC
$1.51 +0.03 (+2.03%)
As of: Oct 21, 2026 · 3:59 PM EDT

Nanoviricides (NNVC) Long-Term Debt Issuances (2020)

Updated

Nanoviricides (NNVC) reported Long-Term Debt Issuances of $1.1 million for FY2020 (year ended Jun 30, 2020).

Analysis

Nanoviricides (NNVC) Long-Term Debt Issuances (2020) Analysis & Trends

  • The FY2020 figure ranks as the highest annual Long-Term Debt Issuances since FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Nanoviricides 30.18 Mn 17.84 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 155,173.00
API Access

Nanoviricides Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=NNVC&period=max&api_key=YOUR_API_KEY